Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Press Release/Announcement

Medication safety issues with newly authorized PAXLOVID.

Medication safety issues with newly authorized PAXLOVID. Institute for Safe Medication Practices. Medication Safety Alerts. January 3, 2022.

Save
Print
January 12, 2022

Institute for Safe Medication Practices. Medication Safety Alerts. January 3, 2022.

Emerging care practices can produce unsafe situations due to the newness of the approaches involved. This alert highlights safety considerations with an oral antiretroviral COVID treatment that include medication administration problems. Safety recommendations are provided for prescribers and pharmacists.

Save
Print
Cite
Citation

Medication safety issues with newly authorized PAXLOVID. Institute for Safe Medication Practices. Medication Safety Alerts. January 3, 2022.